BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26088695)

  • 21. Suppression of influenza virus infection by an N-thioacetylneuraminic acid acrylamide copolymer resistant to neuraminidase.
    Itoh M; Hetterich P; Isecke R; Brossmer R; Klenk HD
    Virology; 1995 Oct; 212(2):340-7. PubMed ID: 7571403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in splitting capacity of virus and V. cholerae neuraminidases on sialic acid type substrates.
    Drzeniek R
    Biochem Biophys Res Commun; 1967 Mar; 26(6):631-8. PubMed ID: 6030973
    [No Abstract]   [Full Text] [Related]  

  • 23. Stimulation of the production of neuraminidase in Vibrio cholerae cultures by N-acetylneuraminic acid and sialyl-lactose.
    FRENCH EL; ADA GL
    J Gen Microbiol; 1959 Dec; 21():550-60. PubMed ID: 13824857
    [No Abstract]   [Full Text] [Related]  

  • 24. Serologic studies of the neuraminidases of Vibrio cholerae, Diplococcus pneumoniae and influenza virus.
    MADOFF MA; EYLAR EH; WEINSTEIN L
    J Immunol; 1960 Dec; 85():603-13. PubMed ID: 13765078
    [No Abstract]   [Full Text] [Related]  

  • 25. Sialosides Containing 7-
    Kooner AS; Yuan Y; Yu H; Kang H; Klenow L; Daniels R; Chen X
    ACS Infect Dis; 2023 Jan; 9(1):33-41. PubMed ID: 36455156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of anomeric ethyl ketosides of 5-N-acetyl-D-neuraminic acid.
    Eschenfelder V; Brossmer R
    Hoppe Seylers Z Physiol Chem; 1979 Sep; 360(9):1253-6. PubMed ID: 511115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative enzyme kinetics of influenza neuraminidases with the synthetic substrate methoxyphenylneuraminic acid.
    Sedmak JJ; Grossberg SE
    Virology; 1973 Dec; 56(2):658-61. PubMed ID: 4757702
    [No Abstract]   [Full Text] [Related]  

  • 28. Trypanosomal Trans-sialidases: Valuable Synthetic Tools and Targets for Medicinal Chemistry.
    Meinke S; Thiem J
    Top Curr Chem; 2015; 367():231-50. PubMed ID: 22648866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biosynthesis of conjugatable saccharidic moieties of GM2 and GM3 gangliosides by engineered E. coli.
    Fort S; Birikaki L; Dubois MP; Antoine T; Samain E; Driguez H
    Chem Commun (Camb); 2005 May; (20):2558-60. PubMed ID: 15900325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetic studies on the acid hydrolysis of the methyl ketoside of unsubstituted and O-acetylated N-acetylneuraminic acid.
    Neuberger A; Ratcliffe WA
    Biochem J; 1973 Aug; 133(4):623-8. PubMed ID: 4748825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemical remodeling of cell-surface sialic acids through a palladium-triggered bioorthogonal elimination reaction.
    Wang J; Cheng B; Li J; Zhang Z; Hong W; Chen X; Chen PR
    Angew Chem Int Ed Engl; 2015 Apr; 54(18):5364-8. PubMed ID: 25765364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specificities of limulin and wheat-germ agglutinin towards some derivatives of GM3 gangliosides.
    Maget-Dana R; Veh RW; Sander M; Roche AC; Schauer R; Monsigny M
    Eur J Biochem; 1981; 114(1):11-6. PubMed ID: 6894280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A microplate assay for sialidase activity using plant lectin binding to N-acetyllactosamine.
    Onodera S
    Biol Pharm Bull; 1994 Jan; 17(1):29-33. PubMed ID: 7511958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The synthesis of a series of deoxygenated 2,3-difluoro-N-acteylneuraminic acid derivatives as potential sialidase inhibitors.
    Hader S; Watts AG
    Carbohydr Res; 2013 Jun; 374():23-8. PubMed ID: 23618621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of neuraminidase activity by derivatives of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid.
    Meindl P; Bodo G; Palese P; Schulman J; Tuppy H
    Virology; 1974 Apr; 58(2):457-63. PubMed ID: 4362431
    [No Abstract]   [Full Text] [Related]  

  • 36. Preparation of sepharose-bound alpha-ketosides of N-acetylneuraminic acid and their interaction with Vibrio cholerae neuraminidase.
    Holmquist L
    Acta Chem Scand B; 1974; 28(9):1065-8. PubMed ID: 4440362
    [No Abstract]   [Full Text] [Related]  

  • 37. Preparation of sialylated oligosaccharides employing recombinant trans-sialidase from Trypanosoma cruzi.
    Neubacher B; Schmidt D; Ziegelmuller P; Thiem J
    Org Biomol Chem; 2005 Apr; 3(8):1551-6. PubMed ID: 15827656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Occurrence of free deaminoneuraminic acid (KDN)-containing complex-type N-glycans in human prostate cancers.
    Yabu M; Korekane H; Hatano K; Kaneda Y; Nonomura N; Sato C; Kitajima K; Miyamoto Y
    Glycobiology; 2013 Jun; 23(6):634-42. PubMed ID: 22975979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 2,3-Didehydro-2-deoxysialic acids structurally varied at C-5 and their behaviour towards the sialidase from Vibrio cholerae.
    Schreiner E; Zbiral E; Kleineidam RG; Schauer R
    Carbohydr Res; 1991 Sep; 216():61-6. PubMed ID: 1797392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of oligomers derived from amide-linked neuraminic acid analogues.
    Gregar TQ; Gervay-Hague J
    J Org Chem; 2004 Feb; 69(4):1001-9. PubMed ID: 14961647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.